Clin2
NCT06635863Possibly a fitEnrolling by invitation

Steroids versus standard heart medications for heart inflammation

Ventricular ArrythmiaNon-ischemic CardiomyopathyArrhythmogenic Inflammatory Cardiomyopathy

Treatments studied

Part of Heart & circulation, Immune system & allergy clinical trials.

This study compares two treatment strategies for people with unexplained heart failure and irregular heartbeats caused by inflammation: one group gets standard heart medications plus an immune-suppressing steroid (prednisone), and the other gets standard medications alone. Doctors want to see whether adding steroids helps improve heart function and control dangerous heart rhythms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and have been diagnosed with heart failure (New York Heart Association class II, III, or stable class IV).
  • Your heart's pumping strength (LVEF) is below 50% on an echocardiogram or similar test.
  • You have had episodes of dangerously fast heart rhythms (sustained VT lasting more than 30 seconds).
  • A PET scan has confirmed inflammation in your heart muscle (myocarditis).
  • You have used steroids (like prednisone) within the last 12 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06158698Recruiting· Phase 3
Colchicine for heart inflammation with arrhythmias

This trial tests whether the drug colchicine can help people with heart muscle inflammation (myocarditis) that also causes abnormal heart rhythms, a weak heart pump, or high stress markers. Colchicine is an anti-inflammatory medicine that might reduce heart damage and improve symptoms.

Naples, Campania
NCT05974462Recruiting· Phase 3
Steroids for mild heart inflammation with weaker pumping

This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.

Edegem, Antwerp
NCT06522100Not yet recruiting· Phase 3
Steroid treatment for acute heart muscle inflammation

This trial tests whether steroids (corticoids) can improve recovery in people with acute myocarditis, which is inflammation of the heart muscle. If you have been recently diagnosed and your heart isn't pumping as well as it should, this treatment might help reduce inflammation and improve heart function.

NCT07461961Not yet recruiting· Phase 2
Corticosteroids for heart failure-related cardiogenic shock

This study tests whether giving a corticosteroid (an anti-inflammatory medicine) can help people with cardiogenic shock caused by heart failure. It is designed for patients who have high inflammation and are in the ICU early in their hospital stay.

Boston, Massachusetts
NCT05150704Recruiting· Phase 3
Steroid treatment for suspected acute myocarditis in hospital

This study tests whether steroid medicine helps people hospitalized with suspected acute myocarditis (inflammation of the heart). Participants are randomly assigned to receive steroids or a placebo, and the trial looks at outcomes after the acute episode starts.

San Diego, California
NCT06896253Not yet recruiting· Phase 2
Steroids or immunoglobulins for severe sudden heart inflammation

This trial tests whether giving steroids, immunoglobulins, or both can help people with a sudden, severe heart muscle inflammation (myocarditis) that causes shock or dangerous heart rhythms. The goal is to see if these treatments improve recovery compared to standard care.

Hear when a new Ventricular Arrythmia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.